dr. M. (René) van Hulst

Researcher

dr. M. (René) van Hulst
E-mail:
m.van.hulst rug.nl

Research

Publications
  1. Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

    de Jong, L. A., Groeneveld, J., Stevanovic, J., Rila, H., Tieleman, R. G., Huisman, M. V., Postma, M. J. & van Hulst, M., 2019, In : PLoS ONE. 14, 9, 17 p., e0222658.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries

    ABO RBDM Health Economics Outcomes, Janssen, M. P., van Hulst, M. & Custer, B., Aug-2017, In : Vox Sanguinis. 112, 6, p. 518-525 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions

    Jacobs, M. S., van Hulst, M., Campmans, Z. & Tieleman, R. G., Jul-2019, In : Netherlands Heart Hournal. 27, 7-8, p. 371-377 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Atrial Fibrillation in Africa-An Underreported and Unrecognized Risk Factor for Stroke: A Systematic Review

    Jacobs, M. S., van Hulst, M., Adeoye, A. M., Tieleman, R. G., Postma, M. J. & Owolabi, M. O., Sep-2019, In : Global heart. 14, 3, p. 269-279

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. To Bridge or Not to Bridge: Modelling Periprocedural Anticoagulation Management

    van der Pol, S., Jacobs, M., Meijer, K., Piersma-Wichers, M. G., Tieleman, RG., Postma, M. & van Hulst, M., 3-Aug-2018, p. E417. 1 p.

    Research output: Contribution to conferencePosterAcademic

View all (49) »

View graph of relations

ID: 90636